Petrillo Francesco, Sinoca Marica, Fea Antonio Maria, Galdiero Marilena, Maione Angela, Galdiero Emilia, Guida Marco, Reibaldi Michele
Department of Medical Sciences, Eye Clinic, Turin University, 10126 Turin, Italy.
Department of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.
Antibiotics (Basel). 2023 Aug 2;12(8):1277. doi: 10.3390/antibiotics12081277.
Fungi represent a very important cause of microbial eye infections, especially in tropical and developing countries, as they could cause sight-threating disease, such as keratitis and ocular candidiasis, resulting in irreversible vision loss. species are among the most frequent microorganisms associated with fungal infection. Although is still the most frequently detected organism among subspecies, an important increase in non- species has been reported. Mycotic infections often represent an important diagnostic-clinical problem due to the difficulties in performing the diagnosis and a therapeutic problem due to the limited availability of commercial drugs and the difficult penetration of antifungals into ocular tissues. The ability to form biofilms is another feature that makes a dangerous pathogen. In this review, a summary of the state-of-the-art panorama about candida ocular pathology, diagnosis, and treatment has been conducted. Moreover, we also focused on new prospective natural compounds, including nanoparticles, micelles, and nanocarriers, as promising drug delivery systems to better cure ocular fungal and biofilm-related infections. The effect of the drug combination has also been examined from the perspective of increasing efficacy and improving the course of infections caused by which are difficult to fight.
真菌是引起眼部微生物感染的一个非常重要的原因,尤其是在热带和发展中国家,因为它们可能导致威胁视力的疾病,如角膜炎和眼部念珠菌病,从而导致不可逆转的视力丧失。某些菌种是与真菌感染相关的最常见微生物之一。尽管在某些亚种中仍最常检测到某种菌,但已报道非该种菌的数量有显著增加。由于诊断困难,霉菌性感染常常是一个重要的诊断临床问题;又由于市售药物供应有限以及抗真菌药物难以渗透到眼组织中,它也是一个治疗难题。形成生物膜的能力是使某种菌成为危险病原体的另一个特征。在本综述中,我们对念珠菌性眼部病理学、诊断和治疗的最新全景进行了总结。此外,我们还关注了新的潜在天然化合物,包括纳米颗粒、胶束和纳米载体,它们作为有前景的药物递送系统,有望更好地治疗眼部真菌和生物膜相关感染。我们还从提高疗效和改善由难以对抗的某种菌引起的感染病程的角度研究了联合用药的效果。